-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Sigilon Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2020 to 2022.
- Sigilon Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending June 30, 2023 was $300K, unchanged year-over-year.
- Sigilon Therapeutics, Inc. Depreciation, Depletion and Amortization for the twelve months ending June 30, 2023 was $1.26M, a 6.4% increase year-over-year.
- Sigilon Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $1.26M, a 13.1% increase from 2021.
- Sigilon Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $1.12M, a 30.9% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)